Inside the research
LifeStance Health Group, Inc.
LFST Research profile · latest available data
Price overview
$11.84
▲ +0.04 (+0.3%)
| 52w hi | $13.38 |
|---|---|
| 52w lo | $4.81 |
| Vol | 7.83M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.75
| Short | +0.82 |
|---|---|
| Medium | +0.82 |
| Long | +0.45 |
computed 2026-09-27
Key fundamentals
LifeStance Health Group, Inc.
Healthcare · Medical Care Facilities
| Market cap | $4.50B |
|---|---|
| Enterprise value | $4.77B |
| Trailing P/E | 91.08x |
| Forward P/E | 22.31x |
| EV / EBITDA | 35.34x |
| P / S (ttm) | 2.84x |
| Profit margin | 3.2% |
| Return on equity | 3.4% |
| Revenue growth | +26.1% |
| Debt / equity | 32.10 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.23 | |
| Sector | +0.08 | |
| Technical | +0.47 | |
| Earnings | +0.00 | |
| Sentiment | +0.25 |
macro × 1.00 · 2026-09-27
Business overview
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
Risk Metrics
| Beta vs SPX | 0.77 |
|---|---|
| Corr SPX | 0.25 |
| Annual vol | 49.0% |
| Annual ret | +39.2% |
| Sharpe | 0.80 |
| Max DD | -53.6% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-06 | Earnings Release, Reg FD Disclosure… | read |
| 2026-07-07 | Officer / Director Change | read |
| 2026-06-04 | Shareholder Vote | read |
| 2026-05-12 | Other Material Event, Exhibits | read |
| 2026-05-07 | Earnings Release, Reg FD Disclosure… | read |
| 2026-03-11 | Officer / Director Change | read |
| 2026-03-02 | Other Material Event, Exhibits | read |
| 2026-02-25 | Earnings Release, Officer / Director Change… | read |
| 2025-11-06 | Earnings Release, Reg FD Disclosure… | read |
| 2025-08-22 | Officer / Director Change | read |
| 2025-08-07 | Earnings Release, Reg FD Disclosure… | read |
| 2025-06-06 | Shareholder Vote | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 9 |
| Top-5 share | 97.0% |
| HHI | 6,165 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| Fidelity / FMR LLC | $623.88M | 58.25M |
| State Street Corp | $88.13M | 8.23M |
| Millennium Management | $38.63M | 3.61M |
| Norges Bank (Norway sovereign) | $16.74M | 1.56M |
| AQR Capital Management | $13.35M | 1.25M |
| Renaissance Technologies | $10.28M | 960.01K |
| Capital Research / Capital World | $7.58M | 707.97K |
| Citadel Advisors | $6.00M | 560.59K |
| T. Rowe Price Group | $29.66K | 2.77M |
As of 2026-06-30
SEC Filings
The Long Run
FY 2021–2025 · 5 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $1.42B | +60.9% | |
| Operating income | -$31.61M | — | |
| Net income | $9.66M | +70.5% | |
| Cash from ops | -$16.88M | +150.8% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $11.77 | $12.05 | $11.76 | $11.84 | 7.83M |
| Sep 24 | $12.13 | $12.17 | $11.78 | $11.80 | 4.26M |
| Sep 23 | $12.50 | $12.51 | $11.75 | $12.08 | 7.62M |
| Sep 22 | $12.69 | $12.91 | $12.52 | $12.55 | 4.04M |
| Sep 21 | $12.56 | $12.72 | $12.40 | $12.67 | 3.31M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →